Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,deferredLongTermLiab,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,netReceivables,longTermDebt,inventory,accountsPayable,changeToLiabilities,totalCashflowsFromInvestingActivities,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,changeToInventory,changeToAccountReceivables,changeToNetincome,capitalExpenditures,netBorrowings,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,gmtOffSetMilliseconds,esgPopulated,tradeable,currency,marketState,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,shortName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,exchangeDataDelayedBy,exchange,priceHint,market,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,state,country,website,maxAge,address1,fax,industry
t0,IMRSQ,-2612000.0,62594000,1742000,,-6693000,,-7067000,5852000,3704000,-4555000,-4555000,,-1358000,,,,374000,9558000,14113000,5854000,-2138000,,-7067000,-7067000,7904000.0,15367000.0,53694000.0,11790000.0,796000.0,16840000.0,65484000.0,168854000.0,371000.0,-174127000.0,945000.0,6498000.0,1696000.0,2012000.0,5002000.0,31723000.0,2456000.0,1696000.0,14311000.0,34759000.0,16911000.0,21026000.0,9130000.0,6810000.0,8959000.0,-584000.0,3000000.0,92000.0,3000000.0,1160000.0,601000.0,-1857000.0,665000.0,-371000.0,365000.0,-5764000.0,288000.0,-213000.0,,3036000.0,en-US,US,EQUITY,False,Delayed Quote,0.0,1.0E-6 - 1.0E-6,1e-06,finmb_4382747,Other OTC,IMRIS Inc.,USD,27062,86958,0.0,0.0,1.0E-6 - 0.04,-0.039999,-0.999975,1e-06,0.04,-14400000,False,False,USD,PRE,-0.582,0.188,0.0023848484,-0.0023838484,-0.9995807,0.0010992592,-0.0010982592,-0.9990903,62,5.3191493e-06,15,America/New_York,EDT,IMRIS INC,1e-06,1628606277,0.0,1e-06,1e-06,1e-06,1000,0,PNK,4,us_market,114.62,,,0.04,0.0,0.0024,0.0011,27.06k,86.96k,62.59M,,,0.00%,0.43%,,,,,,,,,,,,,,,,"Dec 30, 2014","Dec 30, 2014",-105.18%,-80.09%,-19.15%,-129.83%,28.89M,0.55,-4.30%,9.93M,-20.3M,-30.39M,-0.5820,,5M,0.08,23.48M,199.17,1.10,0.19,-10.91M,4.58M,Value,R3T 1N5,,121,"IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide. The company offers VISIUS Surgical Theatres, a surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment. Its VISIUS Surgical Theatre incorporates magnetic resonance imaging, computed tomography, and fluoroscopy into multi-purpose surgical suites to provide intraoperative imaging for specific medical applications by bringing advanced imaging into the operating room (OR). The company sells the VISIUS Surgical Theatres to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular, and cardiovascular markets. It also provides service and extended maintenance contracts, and accessories and disposables. The company was founded in 2005 and is based in Winnipeg, Canada.",Winnipeg,763-203-6300,MB,Canada,http://www.imris.com,86400,100-1370 Sony Place,866-992-3224,
t-1,IMRSQ,39000.0,62594000,1659000,,-8403000,,-8392000,5855000,2387000,-5829000,-5829000,,-1092000,,,,-11000,6924000,12753000,4537000,-2574000,,-8392000,-8392000,8217000.0,13662000.0,44778000.0,14754000.0,913000.0,10128000.0,59532000.0,166959000.0,,-167060000.0,1162000.0,6498000.0,1193000.0,2134000.0,3842000.0,22787000.0,2456000.0,1193000.0,14621000.0,28062000.0,11147000.0,20829000.0,9495000.0,4732000.0,-2986000.0,6940000.0,3000000.0,7000.0,3000000.0,1106000.0,942000.0,-6776000.0,702000.0,7500000.0,-489000.0,3321000.0,633000.0,-447000.0,,5275000.0,en-US,US,EQUITY,False,Delayed Quote,0.0,1.0E-6 - 1.0E-6,1e-06,finmb_4382747,Other OTC,IMRIS Inc.,USD,27062,86958,0.0,0.0,1.0E-6 - 0.04,-0.039999,-0.999975,1e-06,0.04,-14400000,False,False,USD,PRE,-0.582,0.188,0.0023848484,-0.0023838484,-0.9995807,0.0010992592,-0.0010982592,-0.9990903,62,5.3191493e-06,15,America/New_York,EDT,IMRIS INC,1e-06,1628606277,0.0,1e-06,1e-06,1e-06,1000,0,PNK,4,us_market,114.62,,,0.04,0.0,0.0024,0.0011,27.06k,86.96k,62.59M,,,0.00%,0.43%,,,,,,,,,,,,,,,,"Dec 30, 2014","Dec 30, 2014",-105.18%,-80.09%,-19.15%,-129.83%,28.89M,0.55,-4.30%,9.93M,-20.3M,-30.39M,-0.5820,,5M,0.08,23.48M,199.17,1.10,0.19,-10.91M,4.58M,Value,R3T 1N5,,121,"IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide. The company offers VISIUS Surgical Theatres, a surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment. Its VISIUS Surgical Theatre incorporates magnetic resonance imaging, computed tomography, and fluoroscopy into multi-purpose surgical suites to provide intraoperative imaging for specific medical applications by bringing advanced imaging into the operating room (OR). The company sells the VISIUS Surgical Theatres to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular, and cardiovascular markets. It also provides service and extended maintenance contracts, and accessories and disposables. The company was founded in 2005 and is based in Winnipeg, Canada.",Winnipeg,763-203-6300,MB,Canada,http://www.imris.com,86400,100-1370 Sony Place,866-992-3224,
t-2,IMRSQ,6065000.0,62594000,1761000,,-7165000,,-7027000,6164000,1916000,-6711000,-6711000,,-1072000,,,,-138000,4258000,10969000,2342000,-454000,,-7027000,-7027000,8410000.0,12177000.0,48655000.0,20973000.0,1030000.0,13614000.0,69628000.0,166959000.0,7500000.0,-158668000.0,1252000.0,6498000.0,505000.0,2387000.0,2736000.0,25754000.0,1839000.0,505000.0,15028000.0,37305000.0,14468000.0,21649000.0,9006000.0,6209000.0,-2428000.0,-675000.0,3000000.0,-187000.0,3000000.0,-4489000.0,-660000.0,-3154000.0,702000.0,7500000.0,-717000.0,5713000.0,360000.0,-662000.0,,11551000.0,en-US,US,EQUITY,False,Delayed Quote,0.0,1.0E-6 - 1.0E-6,1e-06,finmb_4382747,Other OTC,IMRIS Inc.,USD,27062,86958,0.0,0.0,1.0E-6 - 0.04,-0.039999,-0.999975,1e-06,0.04,-14400000,False,False,USD,PRE,-0.582,0.188,0.0023848484,-0.0023838484,-0.9995807,0.0010992592,-0.0010982592,-0.9990903,62,5.3191493e-06,15,America/New_York,EDT,IMRIS INC,1e-06,1628606277,0.0,1e-06,1e-06,1e-06,1000,0,PNK,4,us_market,114.62,,,0.04,0.0,0.0024,0.0011,27.06k,86.96k,62.59M,,,0.00%,0.43%,,,,,,,,,,,,,,,,"Dec 30, 2014","Dec 30, 2014",-105.18%,-80.09%,-19.15%,-129.83%,28.89M,0.55,-4.30%,9.93M,-20.3M,-30.39M,-0.5820,,5M,0.08,23.48M,199.17,1.10,0.19,-10.91M,4.58M,Value,R3T 1N5,,121,"IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide. The company offers VISIUS Surgical Theatres, a surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment. Its VISIUS Surgical Theatre incorporates magnetic resonance imaging, computed tomography, and fluoroscopy into multi-purpose surgical suites to provide intraoperative imaging for specific medical applications by bringing advanced imaging into the operating room (OR). The company sells the VISIUS Surgical Theatres to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular, and cardiovascular markets. It also provides service and extended maintenance contracts, and accessories and disposables. The company was founded in 2005 and is based in Winnipeg, Canada.",Winnipeg,763-203-6300,MB,Canada,http://www.imris.com,86400,100-1370 Sony Place,866-992-3224,
t-3,IMRSQ,12912000.0,62594000,1602000,,-7884000,,-7901000,5601000,1925000,-6045000,-6045000,,-1055000,,,,17000,8151000,14196000,6226000,-1839000,,-7901000,-7901000,8699000.0,11773000.0,50910000.0,28109000.0,1145000.0,10308000.0,79019000.0,166959000.0,7500000.0,-151641000.0,1419000.0,6498000.0,1018000.0,2770000.0,7225000.0,28150000.0,1242000.0,1018000.0,14574000.0,46478000.0,20181000.0,21341000.0,8289000.0,10658000.0,-246000.0,-1195000.0,500000.0,-229000.0,3000000.0,843000.0,661000.0,877000.0,767000.0,7500000.0,1716000.0,5878000.0,471000.0,-1188000.0,500000.0,18328000.0,en-US,US,EQUITY,False,Delayed Quote,0.0,1.0E-6 - 1.0E-6,1e-06,finmb_4382747,Other OTC,IMRIS Inc.,USD,27062,86958,0.0,0.0,1.0E-6 - 0.04,-0.039999,-0.999975,1e-06,0.04,-14400000,False,False,USD,PRE,-0.582,0.188,0.0023848484,-0.0023838484,-0.9995807,0.0010992592,-0.0010982592,-0.9990903,62,5.3191493e-06,15,America/New_York,EDT,IMRIS INC,1e-06,1628606277,0.0,1e-06,1e-06,1e-06,1000,0,PNK,4,us_market,114.62,,,0.04,0.0,0.0024,0.0011,27.06k,86.96k,62.59M,,,0.00%,0.43%,,,,,,,,,,,,,,,,"Dec 30, 2014","Dec 30, 2014",-105.18%,-80.09%,-19.15%,-129.83%,28.89M,0.55,-4.30%,9.93M,-20.3M,-30.39M,-0.5820,,5M,0.08,23.48M,199.17,1.10,0.19,-10.91M,4.58M,Value,R3T 1N5,,121,"IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide. The company offers VISIUS Surgical Theatres, a surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment. Its VISIUS Surgical Theatre incorporates magnetic resonance imaging, computed tomography, and fluoroscopy into multi-purpose surgical suites to provide intraoperative imaging for specific medical applications by bringing advanced imaging into the operating room (OR). The company sells the VISIUS Surgical Theatres to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular, and cardiovascular markets. It also provides service and extended maintenance contracts, and accessories and disposables. The company was founded in 2005 and is based in Winnipeg, Canada.",Winnipeg,763-203-6300,MB,Canada,http://www.imris.com,86400,100-1370 Sony Place,866-992-3224,
